What is the patented technology of amrit metformin sustained-release microsomes?

The patented technology of rituximab sustained-release microsomes is that it can provide favorable conditions for the rapid absorption of drugs, and rituximab achieves better sustained and stable sustained-release effect. Compared with the common preparation, the release is faster and more stable, which can keep the blood sugar concentration of diabetic patients stable all day. The product is easy to take once a day.